Codice QR

The Role of microRNA-155 as a Biomarker in Diffuse Large B-Cell Lymphoma

Diffuse Large B-cell Lymphoma (DLBCL) is the most common aggressive non-Hodgkin lymphoma (NHL). Despite the use of newer agents, such as polatuzumab vedotin, more than one-third of patients have ultimately relapsed or experienced refractory disease. MiRNAs are single-stranded, ~22-nucleotide-long RN...

Descrizione completa

Salvato in:
Autori principali: Epameinondas Koumpis, Vasileios Georgoulis, Konstantina Papathanasiou, Alexandra Papoudou-Bai, Panagiotis Kanavaros, Evangelos Kolettas, Eleftheria Hatzimichael
Natura: Artigo
Lingua:Inglês
Pubblicazione: MDPI AG 2024-11-01
Serie:Biomedicines
Soggetti:
lymphoma
DLBCL
miRNAs
miR-155
biomarkers
lymphomagenesis
Accesso online:https://www.mdpi.com/2227-9059/12/12/2658
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi